Amino-terminal pro-brain-type natriuretic peptide: Heart or lung disease in pediatric respiratory distress?

Pediatrics

Volumn 115, Issue 5, 2005, Pages 1347-1350

  Cohen, Shlomo ^a   Springer, Chaim ^a   Avital, Avraham ^a   Perles, Zeev ^a   Rein, Azaria J J T ^a   Argaman, Zvi ^b   Nir, Amiram ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Amino terminal pro brain natriuretic peptide; Congestive heart failure; Infants; Respiratory distress

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ARTICLE; CHILD CARE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART DISEASE; HUMAN; INFANT; LUNG DISEASE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; STATISTICAL ANALYSIS; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; EVALUATION; PROSPECTIVE STUDY; RESPIRATORY FAILURE;

ACUTE DISEASE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; LUNG DISEASES; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY;

EID: 25144519755     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1429     Document Type: Article

References (24)

1. Stevenson LW, Perloff JK. The limited availability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884-888
2. Levin E, Gardner D, Samson W. Natriuretic peptides. N Engl J Med. 1998;339:321-327
3. Sudoh T, Kanagawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81
4. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol. 2001;6:661-672
5. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 1993;87:464-469
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167
7. Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 2001;7:21-29
8. Richards AM, Crozier IG, Yaandle TG, Espiner EA, Ikram H, Nicholls MG. Brain natriuretic factor: regional plasma concentrations and correlations with hemodynamic state in cardiac disease. Br Heart J. 1993;69:414-417
9. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem. 2001;38:94-102
10. Karl J, Borgya A, Gallusser A, et al. Development of a novel N-terminal-pro BNP (NT-pro BNP) assay with a low detection limit. Scand J Clin Lab Invest. 1999;230:177-181
11. Downie PF, Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clin Sci (Lond). 1999;97:255-258
12. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohumoral predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 1998;97:1921-1929
13. Hunt PJ, Yandle TG, Nichols MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 1995;214:1175-1183
14. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardivasc Res. 1997;36:246-255
15. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natruretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997;47:287-296
16. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation. 2000;102:865-870
17. Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of amino-terminal proatrial natriuretic peptide and amino-terminal probrain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics. 2003;112:896-899
18. Itoh H, Sagawa N, Hasegawa M, et al. Brain natriuretic peptide levels in the umbilical venous plasma are elevated in fetal distress. Biol Neonate. 1993;64:18-25
19. Holmstrom H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Pediatr. 2001;90:184-191
20. Ikemoto Y, Nogi S, Teraguchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: correlation with pulmonary arterial pressure. Early Hum Dev. 1996;46:55-62
21. Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics. 2002;110(6). Available at: www.pediatrics.org/cgi/content/ full/110/6/e76
22. Morrison LK, Harrison A, Krishnaswamy P, Kasanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiate congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209
23. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994;343:440-444
24. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654